Folate deficiency induces a cell cycle-specific apoptosis in HepG2 cells

Citation
Rfs. Huang et al., Folate deficiency induces a cell cycle-specific apoptosis in HepG2 cells, J NUTR, 129(1), 1999, pp. 25-31
Citations number
40
Categorie Soggetti
Food Science/Nutrition","Endocrinology, Nutrition & Metabolism
Journal title
JOURNAL OF NUTRITION
ISSN journal
00223166 → ACNP
Volume
129
Issue
1
Year of publication
1999
Pages
25 - 31
Database
ISI
SICI code
0022-3166(199901)129:1<25:FDIACC>2.0.ZU;2-F
Abstract
The human hepatoma HepG2 cell line was chosen as a representative of solid tissue-derived cell systems in which folate metabolism and apoptosis induct ion have not been thoroughly investigated. HepG2 cells were cultivated in t he control or folate-deficient media (control media lacking of folate, glyc ine, thymidine and hypoxanthine) for 4 wk. This resulted in a decrease in i ntracellular folate levels to 32% of the control within 1 wk, which was fol lowed by growth arrest and greater cell death rates. These disturbances of folate deficiency coincided with apoptotic induction, as characteristically shown by nucleosomal DNA fragmentation of 180-200 base pair multimers, nuc lear chromatin condensation and positive terminal transferase-mediated dUTP nick end labeling assay. Apoptosis coincided with an accumulation of cells in S-phase, a subsequent G2/M phase block and a significant increase in me an protein content as evaluated by flow cytometric analyses employing a dou ble-staining method. The growth and cell cycle arrest under folate-deficien t conditions was independent of a change of p53 expression as measured by a n enzyme-linked immunosorbent assay. Supplementation of 2 mu mol/L folate n ormalized cell cycles and diminished DNA fragmentation. Taken together, the se data indicate that HepG2 cells cultivated in folate-deficient medium hav e a low folate concentration, decreased growth and viability, and increased apoptotic propensity. This occurrence of apoptosis was associated with a c ell cycle-specific mechanism and independent of p53-mediated pathway.